Martijn van Teffelen

Chapter 2 28 Table 1 Sample characteristics Stratum Statistical dif. Total sample ( N = 376) Non-clinical ( n = 347) Clinical ( n = 29) Z/ Χ 2 / t (p) Age in years, mean ( SD ) 35.15 (14.72) 34.93 (14.97) 37.72 (11) 1.47 (.141) Female, n (%) 280 (74) 266 (77) 14 (48) 11.34 (.001) Male, n (%) 96 (26) 81 (23) 15 (52) Nationality, n (%) 2.05 (.563) Dutch 353 (95) 324 (93) 29 (100) Belgian 13 (3) 13 (4) 0 (0) German 4 (1) 4 (1) 0 (0) Other 6 (2) 6 (2) 0 (0) Education, n (%) 27.46 (< .001) Low 91 (24) 89 (26) 2 (7) Middle 141 (38) 114 (33) 24 (83) High 144 (38) 141 (41) 3 (10) Work situation, n (%) 26.14 (< .001) Employed 155 (41) 141 (41) 14 (48) Unemployed 42 (11) 36 (10) 6 (21) Student 135 (36) 135 (39) 0 (0) Social security 41 (11) 32 (9) 3 (10) Retired 3 (1) 3 (2) 0 (0) Medication use, n (%) Antidepressant, SSRI 24 (6) 16 (5) 8 (28) 23.64 (< .001) Antidepressant, SNRI 10 (3) 5 (1) 5 (17) 25.81 (< .001) Antidepressant, TCA 2 (1) 2 (1) 0 (0) .17 (.682) Antidepressant, other 3 (1) 2 (1) 1 (3) 2.79 (.095) Antipsychotic, atypical 6 (2) 4 (1) 2 (7) 5.62 (.018) Anxiolytic 10 (3) 5 (1) 5 (17) 25.81 (< .001) Mood stabilizer 3 (1) 2 (1) 1 (3) 2.79 (.095) Stimulant 7 (2) 6 (2) 1 (3) .43 (.511) Study variables STAXI-2T, mean ( SD ) 16.67 (5.21) 16.01 (4.53) 24.76 (6.03) -7.63 (< .001) AQH, mean ( SD ) 19.01 (7.25) 18.47 (7.02) 25.45 (7.04) -5.13 (< .001) FOA, mean ( SD ) 56.72 (13.12) 55.57 (11.99) 70.52 (17.78) 4.89 (< .001) PID-5H, mean (SD ) .74 (.59) .66 (.51) 1.65 (.68) -7.69 (< .001) Note. SSRI = selective serotonergic reuptake inhibitor; SNRI = selective noradrenergic reuptake inhibitor; TCA = tricyclic antidepressant.